EUVIMED · CrossrefJournal
Clinical and Experimental Neuroimmunology
ISSN 1759-1961 · Wiley
Latest articles
Bidirectional Neuro‐Immune Interactions of the Orexin/Hypocretin System: A Systematic Review With Conceptual Synthesis
Post‐Immune Checkpoint Inhibitor Paraneoplastic Syndrome Presenting With a Longitudinally Extensive Lesion Confined to the Dorsal Columns of the Spinal Cord
Patient‐Journey Mapping of CIDP Management in the Philippines: A Survey‐Informed Expert Panel Study and Recommendations From Treat CIDP Philippine Working Group
Clinical Outcomes After Apparent Clinical Events Without Radiological Signs ( ACES ) in Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study
Myelitis After Immune Checkpoint Inhibition: When Rare Presentations Demand a Broader Differential Diagnosis
Correction to “Patient‐Journey Mapping of CIDP Management in the Philippines: A Survey‐Informed Expert Panel Study and Recommendations From Treat CIDP Philippine Working Group”
Reproducible Clinical Response and Serial Electrophysiological Improvement With Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy
Neurotrophic and Inflammatory Biomarkers in the Cerebrospinal Fluid of Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
A Historical Overview of Epidemiological Studies on Multiple Sclerosis in Japan
Autoimmune Cerebellar Ataxia Following TNF ‐α Inhibitor Therapy for Rheumatoid Arthritis: A Case Report
Issue Information
Relapse and Neurological Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Secondary Analysis of a Japanese Nationwide Epidemiologic Survey
Response to the Letter to the Editor: “Multiple Sclerosis in Morocco: Impact on Patients' Quality of Life”
Cases of AQP4 ‐Antibody‐Positive Neuromyelitis Optica Spectrum Disorder Successfully Discontinuing Steroids With Satralizumab Treatment: Considerations on the Method of Tapering for Steroids After the Introduction of Satralizumab
The 37th Annual Meeting of the Japanese Society for Neuroimmunology (JSNI)
The Past, Present, and Future of Multiple Sclerosis Clinical Research in Japan
Disability, Cognition, and Quality of Life in Individuals With Multiple Sclerosis: A 2‐Year Cohort Study
Concentration‐Dependent Increase in the Expression of Junctional Adhesion Molecule‐A in Brain Microvascular Endothelial Cells in Response to Proinflammatory Cytokines and Hyperthermic Decrease in the Expression of Vascular Endothelial Cadherin in These Cells
The History of MRI Research in Multiple Sclerosis: A Global Perspective With a Focus on Japan
Successful Use of Tocilizumab in a 2‐Year‐Old Girl With Probable C‐ NORSE / FIRES : A Case Report
Human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications
Successful treatment of multiple sclerosis with refractory rheumatoid arthritis using ofatumumab: A case report
The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome
Circulating inflammatory cytokine levels correlates with cognitive impairment
Cholesterol: A necessary evil from a multiple sclerosis perspective
Microglia communication: Parallels between aging and Alzheimer's disease
Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Role(s) of Leader protein of Saffold virus
Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartments
EUVIMED